It is commonly believed that pathogenic ATP1A3 variants have resulted in a variety of neurological disorders in the last 20 years, such as rapid-onset dystonia parkinsonism, alternating hemiplegia of childhood, and cerebellar ataxia [32]. This evidence concerns the gene ATP1A3 and Parkinsonism.